Not conducted by MedTech Research Group.
doi:10.1016/j.heliyon.2023.e12963 Ikonomidis I, Katogiannis K, Chania C, et al
thetaiotaomicron are capable of suppressing GLP-1 levels and, most importantly, locomotion in an antibiotic-treated mouse model, we first tested locomotor activity in ampicillin-treated mice following the previously described procedure (Fig
Other major players, which include AstraZeneca, Pfizer, Sanofi, Roche, Amgen, and Boehringer Ingelheim, are expanding pipelines via innovation, acquisitions, and partnerships
This means you will also be given a valid prescription from a doctor or pharmacist who is registered with a relevant body such as the General Medical Council (GMC) or the General Pharmaceutical Council (GPhC)
If you are considering this treatment program, please call us